Experimental study on the regulation of erlotinib-induced radiosensitization with an anti-c-MET monoclonal antibody

PURPOSE: Erlotinib is a novel therapeutic agent for cancer treatment. This study was performed to investigate the role of c-MET-PI3K-AKT pathway in the regulation of erlotinib-induced radiosensitization. METHODS: A973 lung adenocarcinoma cells treated with 6 Gy of radiation were incubated in the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Hong-Qing, Zhuang, Hongxia, Bo, Qifu, Guo, Yihang, Wang, Jun, Zhao, Lu-Jun, Yuan, Zhi-Yong, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263203/
https://www.ncbi.nlm.nih.gov/pubmed/25505849
http://dx.doi.org/10.1186/s12935-014-0109-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263203/
https://www.ncbi.nlm.nih.gov/pubmed/25505849
http://dx.doi.org/10.1186/s12935-014-0109-5

Ejemplares similares